Emerging Technologies in the Pharma and Life Sciences Industry — Mixed Reality

You are here: / Emerging Technologies in the Pharma and Life Sciences Industry — Mixed R...

Emerging Technologies in the Pharma
and Life Sciences Industry — Mixed Reality

ABSTRACT

Emerging technologies are quickly playing a greater role in how the Pharmaceutical and Life Sciences Industry collects, stores and interprets its data. Mixed Reality platforms are becoming more widespread in the application of displaying and
interrogating this data. This paper summarises the trials of an initiative supported by KENX USA, TU Dublin and BioPharmaChem Ireland (BPCI). One technology platform, in this case the Microsoft HoloLens 2, was trialled in 3 areas of interest for the industry; namely Remote Equipment Qualifications, Remote Audits & Inspections and Remote Factory Acceptance Testing (FAT).

Download Article

Industry Articles

Newsletters

Editorial Board

Submit A Paper

Membership Sign Up

Sign Up for Newsletter


Donnacha Nagle

CQV Consultant, Jacobs Engineering; University Lecturer, TU Dublin

Donnacha Nagle is a pharmaceutical industry professional based in Ireland. Currently working as a Senior CQV consultant with Jacobs Engineering, he is also a Lecturer with the School of Chemistry & BioPharmaceutical Sciences at Technological University Dublin (TU Dublin).
Donncadh is an experienced validation engineer with over 17 years of experience in all areas of validation including; process/product validation, equipment/automation qualification, facilities qualification, computer system validation, test method validation, and cleaning validation.
Donncadh has ambitions to become an industry leader within the pharmaceutical industry and is part of the Pharmaceutical Regulatory Science Team (PRST), Dublin, Ireland. Currently researching and exploring the role emerging technologies, artificial intelligence and digitalization can play within the pharmaceutical industry. This research involves exploring possible use cases using these technologies while assessing potential regulatory impacts within the pharma and life sciences industries.
Other notable achievements / positions held:
  • Published author with IVT/JVT (USA), KENX (USA) and TU Dublin.
  • Winner of the 2019 Noel Whelan Memorial award (HPRA Academic Award)
  • KENX Insight Editorial Board member
  • Chair of the BPCI Validation group, Ireland.
  • Kneat Gx trained & guest speaker at Kneat VALIDATE 2023 & 2024
  • Designed new Digital Validation Module for TU Dublin 2024

Michael S. Egan

Lead Validation Engineer, Novo Nordisk®, Assistant Lecturer, TU Dublin

Michael Egan is a Lead Validation Engineer based in Ireland with over twenty years’ experience in the pharmaceutical industry. Michael has graduated with distinction from two master’s degree programmes, MEngSc in Pharmaceutical & Biopharmaceutical Engineering from University College Cork and MSc. in Pharmaceutical Validation Technology from TU Dublin, winning the GetReSkilled Award for “Best overall dissertation performance 2015-16”. Michael is also an Assistant Lecturer for TU Dublin.
His knowledge extends to all areas of equipment/systems operation and validation including Equipment & System Qualification, Facility & Utility Qualification, CSV and Process/Cleaning Validation. He has success in the delivery of complex systems and processes through scientific and risk-based methods and approaches and has ambitions to become an industry leader as a technical SME/Design/Principal Engineer.

Quick Links
Media
Follow